Investment

Record venture capital and heated deal environment propelled biotechnology industry forward in 2007, says Ernst & Young’s biotech report for last year.

Ireland’s largest-ever healthcare venture capital fund is making its optimistic debut as one of the UK’s longest-standing VC supporters of high tech start-ups calls it quits. So what’s happening?

High tech VC funding in Israel reached $617 million in the first quarter of 2008, the highest level for seven years,the IVC Research Center of Tel Aviv.

UK biotech Phynova makes a business out of developing traditional medicines, but when it comes to raising money it is pioneering a new, low-cost route to American investors.

Private equity firm Celtic Pharma is launching two new funds worth $1.5 billion in total, to invest in development-stage biotech companies and products.